{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10(8)"],"submitter":["Cui WS"],"pubmed_abstract":["<h4>Background</h4>To evaluate the efficacy and safety of aildenafil citrate in the treatment of erectile dysfunction (ED) in Chinese population.<h4>Methods</h4>A multicenter, randomized, double-blind, placebo-controlled, double-cycle crossover trial was conducted in three medical centers. Male patients with mild to moderate ED were randomized into two groups and received either aildenafil citrate or placebos, followed by a crossover administration after a 7-day washout. The primary outcome was the duration of penile rigidity over 60% measured by RigiScan<sup>®</sup> Plus. Main secondary outcomes were the duration of penile rigidity over 80% and erectile hardness score (EHS).<h4>Results</h4>A total of 60 patients with mild to moderate ED were enrolled in the study and 57 of them completed "],"journal":["Translational andrology and urology"],"pagination":["3358-3367"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8421832"],"repository":["biostudies-literature"],"pubmed_title":["Efficacy and safety of aildenafil citrate in Chinese men with erectile dysfunction: a multicenter, randomized, double-blind, placebo-controlled crossover trial."],"pmcid":["PMC8421832"],"pubmed_authors":["Cui WS","Lei HE","Tian L","Guan RL","Wang T","Zhu SN","Xin ZC","Yao C","Liu JH","Feng YH","Wang J"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy and safety of aildenafil citrate in Chinese men with erectile dysfunction: a multicenter, randomized, double-blind, placebo-controlled crossover trial.","description":"<h4>Background</h4>To evaluate the efficacy and safety of aildenafil citrate in the treatment of erectile dysfunction (ED) in Chinese population.<h4>Methods</h4>A multicenter, randomized, double-blind, placebo-controlled, double-cycle crossover trial was conducted in three medical centers. Male patients with mild to moderate ED were randomized into two groups and received either aildenafil citrate or placebos, followed by a crossover administration after a 7-day washout. The primary outcome was the duration of penile rigidity over 60% measured by RigiScan<sup>®</sup> Plus. Main secondary outcomes were the duration of penile rigidity over 80% and erectile hardness score (EHS).<h4>Results</h4>A total of 60 patients with mild to moderate ED were enrolled in the study and 57 of them completed ","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Aug","modification":"2025-04-04T09:36:55.412Z","creation":"2025-04-04T09:36:55.412Z"},"accession":"S-EPMC8421832","cross_references":{"pubmed":["34532260"],"doi":["10.21037/tau-21-441"]}}